Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Canada

FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

(Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday.

The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.

Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
Prince Edward Island Issues 223 Canada Immigration Invitations In First PNP Draw Of 2023
Canada Doubles Number Of Out-Of-Status Toronto Construction Workers Eligible For Permanent Residence
Express Entry Now Allows Estheticians To Immigrate To Canada
Quebec Releases Details Of Draw Issuing 1,000 Canada Immigration Invitations
Alberta To Give PNP Preference To Immigrants With Family In Province

Leave a Reply

Your email address will not be published. Required fields are marked *